Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKinsey
Express Scripts
Boehringer Ingelheim
Dow
Harvard Business School
AstraZeneca

Last Updated: October 23, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR COLESEVELAM HYDROCHLORIDE

See Plans and Pricing

« Back to Dashboard

Clinical Trials for Colesevelam Hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00145574 Efficacy and Safety of Colesevelam in Pediatric Patients With Genetic High Cholesterol Completed Daiichi Sankyo Inc. Phase 4 2005-11-01 This study will evaluate the lipid-lowering effect and safety of colesevelam therapy administered to heterozygous familial pediatric patients 10 through 17 years of age who are on a stable dose of a pediatric-approved statin monotherapy (atorvastatin, lovastatin, simvastatin or pravastatin), or who are treatment naive to lipid-lowering therapy.
NCT00147719 WelChol® With Metformin in Treating Patients With Type 2 Diabetes Completed Daiichi Sankyo Inc. Phase 3 2004-06-01 The purpose of the study is to see how safe and effective and tolerable the use of colesevelam hydrochloride is for type 2 diabetes when added to metformin alone or in combination with other anti-diabetic drugs.
NCT00147745 Effects of Colesevelam on How the Body Responds to Insulin in Patients With Type 2 Diabetes Completed Daiichi Sankyo Inc. Phase 2 2005-06-01 This study is designed to assess the potential mechanism of action by which WelChol® (colesevelam) may improve blood glucose control in patients with type 2 diabetes
NCT00147758 WelChol® and Sulfonylurea in Treating Patients With Type 2 Diabetes Completed Daiichi Sankyo Inc. Phase 3 2004-06-01 The purpose of the study is to see how safe and effective and tolerable the use of colesevelam hydrochloride is for type 2 diabetes when added to sulfonylurea alone or in combination with other anti-diabetic drugs.
NCT00151762 Long-Term Study of Safety and Efficacy of WelChol® as an Additional Therapy in Patients With Type 2 Diabetes Completed Daiichi Sankyo Inc. Phase 3 2004-12-01 This extension study is designed to evaluate the long-term safety and tolerability of colesevelam hydrochloride (WelChol®) in patients with type 2 diabetes.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Colesevelam Hydrochloride

Condition Name

Condition Name for Colesevelam Hydrochloride
Intervention Trials
Type 2 Diabetes 9
Type 2 Diabetes Mellitus 5
Bile Acid Malabsorption 5
Hypercholesterolemia 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Colesevelam Hydrochloride
Intervention Trials
Diabetes Mellitus, Type 2 15
Diabetes Mellitus 11
Hypercholesterolemia 6
Diarrhea 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Colesevelam Hydrochloride

Trials by Country

Trials by Country for Colesevelam Hydrochloride
Location Trials
United States 156
Mexico 9
Denmark 7
Canada 6
India 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Colesevelam Hydrochloride
Location Trials
California 12
Minnesota 11
Texas 10
Florida 9
New York 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Colesevelam Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Colesevelam Hydrochloride
Clinical Trial Phase Trials
Phase 4 18
Phase 3 7
Phase 2/Phase 3 2
[disabled in preview] 9
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Colesevelam Hydrochloride
Clinical Trial Phase Trials
Completed 29
Recruiting 9
Not yet recruiting 3
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Colesevelam Hydrochloride

Sponsor Name

Sponsor Name for Colesevelam Hydrochloride
Sponsor Trials
Daiichi Sankyo Inc. 18
Mayo Clinic 6
University of Copenhagen 3
[disabled in preview] 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Colesevelam Hydrochloride
Sponsor Trials
Other 39
Industry 29
NIH 5
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Mallinckrodt
McKinsey
Harvard Business School
Baxter
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.